Baskhanbio Pharma Inc. (XKON:354390)
South Korea · Delayed Price · Currency is KRW 4,885.00
+230.00 (4.94%)
Last updated: Dec 15, 2025, 12:25 PM KST
Baskhanbio Pharma Market Cap
Baskhanbio Pharma has a market cap or net worth of 34.04 billion as of December 16, 2025. Its market cap has decreased by -13.24% in one year.
Market Cap
34.04B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
4,885.00
Market Cap Chart
Since July 20, 2022, Baskhanbio Pharma's market cap has decreased from 82.82B to 34.04B, a decrease of -58.90%. That is a compound annual growth rate of -22.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 15, 2025 | 34.04B | 13.05% |
| Dec 30, 2024 | 30.11B | -36.91% |
| Dec 28, 2023 | 47.72B | 16.64% |
| Dec 29, 2022 | 40.92B | -50.59% |
| Jul 20, 2022 | 82.82B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 714.59T |
| SK hynix | 394.25T |
| LG Energy Solution | 104.25T |
| Samsung Biologics | 78.32T |
| Hyundai Motor Company | 65.39T |
| Doosan Enerbility | 51.05T |
| HD Hyundai Heavy Industries | 50.87T |
| Hanwha Aerospace | 49.44T |